Pinetree Therapeutics

Pinetree Therapeutics is a biotechnology company developing next-generation targeted protein degraders (TPDs) to overcome drug resistance in oncology and other therapeutic areas. Their AbReptor platform uses a novel mechanism to degrade proteins, improving treatment outcomes. The company is advancing multiple preclinical candidates with potential applications in various cancers and other diseases.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $17M

Date: 30-Jul-2024

Investors: STIC Investments, DSC Investment, Atinum Investment, Quantum FA, S&S Investment, DSC Investment, Schmidt, SGI Partners

Markets: Biotechnology, Oncology, Therapeutics

HQ: Cambridge, Massachusetts, United States

Founded: 2019

Website: https://www.pinetreetx.com/

LinkedIn: https://www.linkedin.com/company/pinetree-therapeutics/

Twitter:

Instagram: